Celularity Inc. (CELUW)
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies
NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers
ChronoScale Appoints Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer to Accelerate Global AI Infrastructure Strategy
Provident Bank Names Annamaria Vitelli EVP, Chief Wealth Officer and President of Beacon Trust
VCI Global Provides Strategic Business Update as Institutional Shareholder Base Expands
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
New Leidos SATCOM tool boosts combat connectivity, effectiveness
Kairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholders
Cimpress to Present at the 16th Annual East Coast Ideas Conference on June 11, 2026 in New York
FICO Score 10T Now Integrated Into Optimal Blues Capital Markets Platform